semaglutide compounded cost What is semaglutide? Benefits, risks, and costs Eden Reviewed: 2026 Consumer Report

Because new Phase 3 obesity results announced in May 2026 drew major attention to its weight-loss potential

Most people will encounter 10mg/ml or 20mg/ml concentrations

Choose Retatrutide If: Maximum weight loss is the primary goal Previous GLP-1 agonists produced significant nausea (GIP component may help) No specific liver health concerns requiring treatment Tolerance for slightly higher GI side effects during titration Response to dual agonists (like tirzepatide) has been positive Choose Survodutide If: Liver health concerns exist (fatty liver, MASH, elevated liver enzymes) Moderate weight loss goals rather than maximum efficacy priority Interest in potential cardiovascular outcome benefits (CVOT data pending) Preference for a compound with FDA Breakthrough Therapy designation Plans to potentially transition to approved medication once available For most people focused primarily on weight loss, Retatrutide presents the stronger option based on available data

The combined receptor activation produces measurable outcomes distinct from single or dual-receptor activation alone

The FDA has distinguished between mass-marketed compounded products and patient-specific compounding performed under Section 503A of the FD&C Act, which may remain permissible in narrow circumstances where a patient's medical needs cannot be met by an FDA-approved drug